Answers are grounded in this paper and cite their sources.
As of 2020, 19.000.000 new cancer cases were detected worldwide of which 5% (950.000) were found in patients under 40 years of age at the time of diagnosis. All of them can be seen as potential candidates for a fertility-sparing treatment prior, during or after main canther therapy. Among female patients of this group breast cancer, cervical cancer, melanoma and hematologic malignancies are most prevalent. This article reviews proven oncologically safe surgical and conservative fertility-sparing approaches for each individual disease as well as embryological techniques available to achieve pregnancies.
No takes yet. Share an insight, caveat, or question.
Adamyan et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: